Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation

Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation

Abstract Background Autologous hematopoietic stem cell transplantation (AHSCT) has been increasingly used for treatment of relapsing-remitting multiple sclerosis (RRMS). Existing data suggest that AHSCT might alter the natural course of multiple sclerosis (MS) and postpone or even prevent the occurr...

Full description

Saved in:
Bibliographic Details
Main Authors: Ida Erngren, Katarina Lundblad, Ivan Pavlovic, Asma Al-Grety, Anders Larsson, Kim Kultima, Joachim Burman
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Neuroinflammation
Subjects:
Multiple sclerosis
CSF
Autologous hematopoietic stem cell transplantation
Biomarker
YKL-40
GDF-15
Online Access:https://doi.org/10.1186/s12974-025-03511-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12974-025-03511-6

Similar Items